Skip to main content

Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin


A 63-year-old man was admitted to our hospital because he complained of fever and productive cough; this was associated with cavitary infiltrates on his chest X-ray. Although several antibiotics were given, his symptoms did not improve. Bronchofiberscope investigation yielded Aspergillus fumigatus; thus, he was diagnosed with chronic necrotizing pulmonary aspergillosis. Itraconazole, 200 mg/day, was given, and his symptoms and infiltrates on chest X-ray gradually improved. After 2 months of treatment, new infiltrates appeared on a chest X-ray. Antibacterial agents had also shown no effect, and voriconazole was substituted for itraconazole. However, the infiltrates progressed in spite of the voriconazole administration. We added micafungin to the voriconazole treatment. Both his symptoms and the infiltrates on chest X-rays improved. Because voriconazole is thought to be the most effective agent against Aspergillus spp., it is difficult to treat cases that are refractory to voriconazole. The treatment of this case provides invaluable information on how to treat pulmonary aspergillosis related to diseases other than hematologic malignancies.

This is a preview of subscription content, access via your institution.


  1. InstitutionalAuthorNameGuideline committee of deep fungal infection (2003) Diagnosis and treatment guideline for deep fungal infection Ishiyaku Tokyo

    Google Scholar 

  2. T Obayashi M Yoshida T Mori H Goto A Yasuoka H Iwasaki et al. (1995) ArticleTitlePlasma (1→3)-β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes Lancet 345 17–20 Occurrence Handle7799700 Occurrence Handle10.1016/S0140-6736(95)91152-9 Occurrence Handle1:STN:280:DyaK2M%2FpslKrsw%3D%3D

    PubMed  Article  CAS  Google Scholar 

  3. J Maertens J Verhaegen (1999) ArticleTitleAutopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis J Clin Microbiol 37 3223–8 Occurrence Handle10488181 Occurrence Handle1:CAS:528:DyaK1MXmsFektrc%3D

    PubMed  CAS  Google Scholar 

  4. InstitutionalAuthorNameEORTC International Antimicrobial Therapy Cooperative Group (1989) ArticleTitleEmpiric antifungal therapy in febrile granulocytopenic patients Am J Med 86 668–72 Occurrence Handle10.1016/0002-9343(89)90441-5

    Article  Google Scholar 

  5. DA Stevens VL Kan MA Judson VA Morrison S Dummer DW Denning et al. (2000) ArticleTitlePractice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America Clin Infect Dis 30 696–709 Occurrence Handle10770732 Occurrence Handle10.1086/313756 Occurrence Handle1:STN:280:DC%2BD3czotl2hsQ%3D%3D

    PubMed  Article  CAS  Google Scholar 

  6. R Herbrecht DW Denning TF Patterson JE Bennett RE Greene JW Oestmann et al. (2002) ArticleTitleVoriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408–15 Occurrence Handle12167683 Occurrence Handle10.1056/NEJMoa020191 Occurrence Handle1:CAS:528:DC%2BD38XlvFKrt7o%3D

    PubMed  Article  CAS  Google Scholar 

  7. PK Mukherjee DJ Sheehan CA Hitchcock MA Ghannoum (2005) ArticleTitleCombination treatment of invasive fungal infections Clin Microbiol Rev 18 163–94 Occurrence Handle15653825 Occurrence Handle10.1128/CMR.18.1.163-194.2005 Occurrence Handle1:CAS:528:DC%2BD2MXhs1Oms7k%3D

    PubMed  Article  CAS  Google Scholar 

  8. MD Johnson C MacDougall L Ostrosky-Zeichner JR Perfect JH Rex (2004) ArticleTitleCombination antifungal therapy Antimicrob Agents Chemother 48 693–715 Occurrence Handle14982754 Occurrence Handle10.1128/AAC.48.3.693-715.2004 Occurrence Handle1:CAS:528:DC%2BD2cXitVGhsLk%3D

    PubMed  Article  CAS  Google Scholar 

  9. KA Marr M Boeckh RA Carter HW Kim L Corey (2004) ArticleTitleCombination antifungal therapy for invasive aspergillosis Clin Infect Dis 39 797–802 Occurrence Handle15472810 Occurrence Handle10.1086/423380 Occurrence Handle1:CAS:528:DC%2BD2cXoslent7o%3D

    PubMed  Article  CAS  Google Scholar 

  10. J Arroyo G Medoff GS Kobayashi (1977) ArticleTitleTherapy of murine aspergillosis with amphotericin B in combination with rifampin or 5-fluorocytosine Antimicrob Agents Chemother 11 21–5 Occurrence Handle319750 Occurrence Handle1:STN:280:DyaE2s7htVGitg%3D%3D

    PubMed  CAS  Google Scholar 

  11. A Schaffner A Bohler (1993) ArticleTitleAmphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism Mycoses 36 421–4 Occurrence Handle7935575 Occurrence Handle1:STN:280:DyaK2M%2FitFCktg%3D%3D Occurrence Handle10.1111/j.1439-0507.1993.tb00732.x

    PubMed  CAS  Article  Google Scholar 

  12. AI Popp MH White T Quadri L Walshe D Armstrong (1999) ArticleTitleAmphotericin B with and without itraconazole for invasive aspergillosis: a 3-year retrospective study Int J Infect Dis 3 157–60 Occurrence Handle10460928 Occurrence Handle10.1016/S1201-9712(99)90038-3 Occurrence Handle1:STN:280:DyaK1MzptF2ltg%3D%3D

    PubMed  Article  CAS  Google Scholar 

  13. WR Kirkpatrick S Perea BJ Coco TF Patterson (2002) ArticleTitleEfficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis Antimicrob Agents Chemother 46 2564–8 Occurrence Handle12121933 Occurrence Handle10.1128/AAC.46.8.2564-2568.2002 Occurrence Handle1:CAS:528:DC%2BD38XlsFGit7Y%3D

    PubMed  Article  CAS  Google Scholar 

  14. DW Denning KA Marr WM Lau DP Facklam V Ratanatharathorn C Becker et al. (2006) ArticleTitleMicafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis J Infect 53 337–49 Occurrence Handle16678903 Occurrence Handle10.1016/j.jinf.2006.03.003

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Masaki Fujita.

About this article

Cite this article

Ouchi, H., Fujita, M., Ikegame, S. et al. Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin. J Infect Chemother 13, 258–262 (2007).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

Key words

  • Lung aspergillosis
  • Voriconazole
  • Micafungin